My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 109

    1.

    Does topical brimonidine tartrate help NAION?

    Fazzone HE, Kupersmith MJ, Leibmann J.

    Br J Ophthalmol. 2003 Sep;87(9):1193-4. No abstract available. PMID: 12928304 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trial.

    Wilhelm B, Lüdtke H, Wilhelm H; BRAION Study Group.

    Graefes Arch Clin Exp Ophthalmol. 2006 May;244(5):551-8. Epub 2005 Sep 8.PMID: 16151785 [PubMed - indexed for MEDLINE]Related articles

    3.

    Neuroprotective effects of brimonidine treatment in a rodent model of ischemic optic neuropathy.

    Danylkova NO, Alcala SR, Pomeranz HD, McLoon LK.

    Exp Eye Res. 2007 Feb;84(2):293-301. Epub 2006 Nov 16.PMID: 17113077 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effect of brimonidine tartrate 0.15% on night-vision difficulty and contrast testing after refractive surgery.

    Edwards JD, Burka JM, Bower KS, Stutzman RD, Sediq DA, Rabin JC.

    J Cataract Refract Surg. 2008 Sep;34(9):1538-41.PMID: 18721716 [PubMed - indexed for MEDLINE]Related articles

    5.

    Does levodopa improve visual function in NAION?

    Cox TA.

    Ophthalmology. 2000 Aug;107(8):1431. No abstract available. PMID: 10919876 [PubMed - indexed for MEDLINE]Related articles

    6.

    Does Levodopa improve visual function in NAION?

    Hayreh SS.

    Ophthalmology. 2000 Aug;107(8):1434-8. No abstract available. Erratum in: Ophthalmology 2000 Oct;107(10):1804. PMID: 10919878 [PubMed - indexed for MEDLINE]Related articles

    7.

    Does Levodopa improve visual function in NAION?

    Beck RW.

    Ophthalmology. 2000 Aug;107(8):1431-4; discusson 1435-8. No abstract available. PMID: 10919877 [PubMed - indexed for MEDLINE]Related articles

    8.

    Efficacy of levodopa and carbidopa on visual function in patients with non-arteritic anterior ischaemic optic neuropathy.

    Simsek T, Eryilmaz T, Acaroglu G.

    Int J Clin Pract. 2005 Mar;59(3):287-90.PMID: 15857324 [PubMed - indexed for MEDLINE]Related articles

    9.

    Selectivity of site of action and systemic effects of topical alpha agonists.

    Robin AL, Burnstein Y.

    Curr Opin Ophthalmol. 1998 Apr;9(2):30-3. Review.PMID: 10180510 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prophylaxis for second eye involvement in leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite.

    Newman NJ, Biousse V, David R, Bhatti MT, Hamilton SR, Farris BK, Lesser RL, Newman SA, Turbin RE, Chen K, Keaney RP.

    Am J Ophthalmol. 2005 Sep;140(3):407-15.PMID: 16083844 [PubMed - indexed for MEDLINE]Related articles

    11.

    A pilot study of topical treatment with an alpha2-agonist in patients with retinal dystrophies.

    Merin S, Obolensky A, Farber MD, Chowers I.

    J Ocul Pharmacol Ther. 2008 Feb;24(1):80-6.PMID: 18201138 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effect of brimonidine tartrate ophthalmic solution 0.2% on pupil size in normal eyes under different luminance conditions.

    McDonald JE 2nd, El-Moatassem Kotb AM, Decker BB.

    J Cataract Refract Surg. 2001 Apr;27(4):560-4.PMID: 11311624 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effect of brimonidine tartrate 0.2% ophthalmic solution on pupil size.

    Kesler A, Shemesh G, Rothkoff L, Lazar M.

    J Cataract Refract Surg. 2004 Aug;30(8):1707-10.PMID: 15313294 [PubMed - indexed for MEDLINE]Related articles

    14.

    Neuroprotective effect of topically applied brimonidine tartrate 0.2% in endothelin-1-induced optic nerve ischaemia model.

    Aktaş Z, Gürelik G, Akyürek N, Onol M, Hasanreisoğlu B.

    Clin Experiment Ophthalmol. 2007 Aug;35(6):527-34.PMID: 17760634 [PubMed - indexed for MEDLINE]Related articles

    15.

    Is brimonidine ophthalmic a safe therapy for infants?

    Daubert GP.

    J Clin Pharm Ther. 2006 Jun;31(3):289-92.PMID: 16789995 [PubMed - indexed for MEDLINE]Related articles

    16.

    Topical brimonidine reduces collateral damage caused by laser photocoagulation for choroidal neovascularization.

    Ferencz JR, Gilady G, Harel O, Belkin M, Assia EI.

    Graefes Arch Clin Exp Ophthalmol. 2005 Sep;243(9):877-80. Epub 2005 Mar 23.PMID: 15785924 [PubMed - indexed for MEDLINE]Related articles

    17.

    Pupillographic, tonographic and refractive parameter changes after topical instillation of Brimonidine tartrate 0.2% in healthy subjects.

    Brogliatti B, Bogetto C, Prandi B, Boles Carenini B.

    Acta Ophthalmol Scand Suppl. 1998;(227):34-5. No abstract available. PMID: 9972337 [PubMed - indexed for MEDLINE]Related articles

    18.

    Incipient nonarteritic anterior ischemic optic neuropathy.

    Hayreh SS, Zimmerman MB.

    Ophthalmology. 2007 Sep;114(9):1763-72. Epub 2007 Mar 27.PMID: 17391767 [PubMed - indexed for MEDLINE]Related articles

    19.

    Systemic side effects of ophthalmic drops.

    Levy Y, Zadok D.

    Clin Pediatr (Phila). 2004 Jan-Feb;43(1):99-101.PMID: 14968900 [PubMed - indexed for MEDLINE]Related articles

    20.

    Miotic effect of brimonidine tartrate 0.15% ophthalmic solution in normal eyes.

    Thordsen JE, Bower KS, Warren BB, Stutzman R.

    J Cataract Refract Surg. 2004 Aug;30(8):1702-6.PMID: 15313293 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity